PENILE SCARRING WITH INTRACAVERNOUS INJECTION THERAPY USING PROSTAGLANDIN-E1 - A RISK FACTOR-ANALYSIS

Purpose: We attempted to identify risk factors for penile scarring in patients using prostaglandin El injection therapy. Materials and Metho ds: Records of 92 patients using prostaglandin El therapeutically were reviewed. With statistical methods, patients with (15) and without (7 7) scarring were compared. Results: No significant differences between the 2 groups were found regarding duration of followup, injection fre quency, prostaglandin El dose per injection, total number of injection s or total prostaglandin El dose. Patients with initial penile scarrin g did not have a significantly higher incidence of further scarring wi th prostaglandin E1. Conclusions: Penile scarring with prostaglandin E l injection therapy is sporadic and unpredictable. Patients with initi al penile scarring do not have a higher incidence of further scarring.